Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide

Paul K. Fyfe; Vincenzo A. Rao; Aleksandra Zemla; Scott Cameron; William N. Hunter

doi:10.1002/anie.200903407

Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide

Paul K. Fyfe, Vincenzo A. Rao, Aleksandra Zemla, Scott Cameron, William N. Hunter

Research output: Contribution to journal › Article › peer-review

44 Citations (Scopus)

Abstract

TB or not TB active: The high-resolution crystal structures (see picture) of the zinccontaining metalloenzyme nicotinamidase in complex with nicotinic acid and pyrazinoic acid reveal new aspects of enzyme mechanism that help to explain the activation of a front-line anti-tuberculosis (TB) drug.

Original language	English
Pages (from-to)	9176-9179
Number of pages	4
Journal	Angewandte Chemie - International Edition
Volume	48
Issue number	48
Early online date	26 Oct 2009
DOIs	https://doi.org/10.1002/anie.200903407
Publication status	Published - 16 Nov 2009

Access to Document

10.1002/anie.200903407

Fingerprint Dive into the research topics of 'Specificity and mechanism of <i>Acinetobacter baumanii </i>nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide'. Together they form a unique fingerprint.

Cite this

@article{3e71dfefc4354bbd8429a27b137e3089,

title = "Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide",

abstract = "TB or not TB active: The high-resolution crystal structures (see picture) of the zinccontaining metalloenzyme nicotinamidase in complex with nicotinic acid and pyrazinoic acid reveal new aspects of enzyme mechanism that help to explain the activation of a front-line anti-tuberculosis (TB) drug.",

author = "Fyfe, {Paul K.} and Rao, {Vincenzo A.} and Aleksandra Zemla and Scott Cameron and Hunter, {William N.}",

year = "2009",

month = nov,

day = "16",

doi = "10.1002/anie.200903407",

language = "English",

volume = "48",

pages = "9176--9179",

journal = "Angewandte Chemie - International Edition",

issn = "1433-7851",

publisher = "John Wiley and Sons Ltd",

number = "48",

}

Specificity and mechanism of Acinetobacter baumanii nicotinamidase : implications for activation of the front-line tuberculosis drug pyrazinamide. / Fyfe, Paul K.; Rao, Vincenzo A.; Zemla, Aleksandra; Cameron, Scott; Hunter, William N.

In: Angewandte Chemie - International Edition, Vol. 48, No. 48, 16.11.2009, p. 9176-9179.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Specificity and mechanism of Acinetobacter baumanii nicotinamidase

T2 - implications for activation of the front-line tuberculosis drug pyrazinamide

AU - Fyfe, Paul K.

AU - Rao, Vincenzo A.

AU - Zemla, Aleksandra

AU - Cameron, Scott

AU - Hunter, William N.

PY - 2009/11/16

Y1 - 2009/11/16

N2 - TB or not TB active: The high-resolution crystal structures (see picture) of the zinccontaining metalloenzyme nicotinamidase in complex with nicotinic acid and pyrazinoic acid reveal new aspects of enzyme mechanism that help to explain the activation of a front-line anti-tuberculosis (TB) drug.

AB - TB or not TB active: The high-resolution crystal structures (see picture) of the zinccontaining metalloenzyme nicotinamidase in complex with nicotinic acid and pyrazinoic acid reveal new aspects of enzyme mechanism that help to explain the activation of a front-line anti-tuberculosis (TB) drug.

U2 - 10.1002/anie.200903407

DO - 10.1002/anie.200903407

M3 - Article

C2 - 19859929

AN - SCOPUS:70449562067

VL - 48

SP - 9176

EP - 9179

JO - Angewandte Chemie - International Edition

JF - Angewandte Chemie - International Edition

SN - 1433-7851

IS - 48

ER -